A Case Report on Nevirapine Induced Autoimmune Hemolytic Anemia
Meghana Devulapalli1★, Narasimha Kumar G.V2★ Corresponding author
- 1Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupathi, AP, INDIA.
- 2Department of Pharmacology, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupathi, AP, INDIA.
CORRESPONDENCE
Meghana Devulapalli
Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupathi, AP, INDIA.
Received: 12-02-2016; Revised: 18-03-2016; Accepted: 02-04-2016.
Volume 2, Issue 3 · pp. 94–95 · PUBLISHED · DOI: 10.5530/jppcm.2016.3.6
ABSTRACT
Nevirapine is one of the first line agents of the anti-retroviral therapy (ART) used widely in the management of human immunodeficiency virus (HIV) infection and also in acquired immunodeficiency syndrome (AIDS). Anemia is often reported in the individuals taking ART. We report a case of Nevirapine induced autoimmune haemolytic anemia (AIHA). This case report creates awareness on the hematologic abnormality caused by the drug requiring immediate medical attention.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Devulapalli, M., & G.V, N. K. (). A Case Report on Nevirapine Induced Autoimmune Hemolytic Anemia. Journal of Pharmacy Practice and Community Medicine, 2(3), 94–95. https://doi.org/10.5530/jppcm.2016.3.6
